NZ600362A - Topical foam composition - Google Patents

Topical foam composition

Info

Publication number
NZ600362A
NZ600362A NZ600362A NZ60036210A NZ600362A NZ 600362 A NZ600362 A NZ 600362A NZ 600362 A NZ600362 A NZ 600362A NZ 60036210 A NZ60036210 A NZ 60036210A NZ 600362 A NZ600362 A NZ 600362A
Authority
NZ
New Zealand
Prior art keywords
mixture
water
composition
rifaximin
preservative
Prior art date
Application number
NZ600362A
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of NZ600362A publication Critical patent/NZ600362A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams

Abstract

A topical foam pharmaceutical composition for rectal administration comprising rifaximin and a vehicle comprising a water soluble alkanol (alcohol) and water is described. Also described is a method of making the composition comprising: (1) heating a mixture of emulsifier and surfactant to form an oily phase; (2) separately heating a mixture of a preservative and water; (3) adding a water soluble alkanol to the preservative-water mixture and then mixing with oily phase of step (1); and (4) adding rifaximin to the mixture formed in step (3) and adjusting the pH to a desired value using a pH adjusting agent.and the use of the composition to as a medicament. Also disclosed is the use of such compositions in treating a disorder of therectum, colon, terminal ileum or anus.
NZ600362A 2009-11-23 2010-11-23 Topical foam composition NZ600362A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2703MU2009 2009-11-23
PCT/GB2010/002164 WO2011061519A2 (en) 2009-11-23 2010-11-23 Topical foam composition

Publications (1)

Publication Number Publication Date
NZ600362A true NZ600362A (en) 2014-08-29

Family

ID=43447946

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ600362A NZ600362A (en) 2009-11-23 2010-11-23 Topical foam composition

Country Status (12)

Country Link
EP (1) EP2503989A2 (en)
JP (1) JP2013511570A (en)
KR (1) KR20120117788A (en)
CN (1) CN102724960A (en)
AU (1) AU2010320656B2 (en)
BR (1) BR112012012316A2 (en)
CA (1) CA2781580A1 (en)
MX (1) MX2012005883A (en)
NZ (1) NZ600362A (en)
RU (1) RU2012126084A (en)
WO (1) WO2011061519A2 (en)
ZA (1) ZA201204018B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1698630T3 (en) 2005-03-03 2014-12-31 Alfasigma Spa New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ITBO20050123A1 (en) 2005-03-07 2005-06-06 Alfa Wassermann Spa GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA
ES2326387T3 (en) 2005-03-24 2009-10-08 Nolabs Ab COSMETIC TREATMENT WITH NITRIC OXIDE, DEVICE FOR CARRYING OUT SUCH TREATMENT AND MANUFACTURING PROCEDURE OF THE SAME.
BR112012003792B1 (en) 2009-08-21 2020-05-19 Novan Inc topical composition, and, use of topical composition
IT1398550B1 (en) 2010-03-05 2013-03-01 Alfa Wassermann Spa RIFAXIMINA COMPREHENSIVE FORMULATIONS USEFUL TO OBTAIN A PROLONGED EFFECT IN TIME
BR112014000178A2 (en) 2011-07-05 2017-02-07 Novan Inc topical compositions
ITBO20110461A1 (en) 2011-07-29 2013-01-30 Alfa Wassermann Spa PHARMACEUTICAL COMPOSITIONS INCLUDING RIFAXIMINA, PROCESSES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS.
WO2013138075A1 (en) * 2012-03-14 2013-09-19 Novan, Inc. Nitric oxide releasing pharmaceutical compositions
ITBO20120368A1 (en) 2012-07-06 2014-01-07 Alfa Wassermann Spa COMPOSITIONS INCLUDING RIFAXIMINA AND AMINO ACIDS, RIFAXIMINE CRYSTALS DERIVING FROM SUCH COMPOSITIONS AND THEIR USE.
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
HUE050054T2 (en) 2014-05-12 2020-11-30 Alfasigma Spa Preparation and use of crystalline form tau of rifaximin solvated with degme
EP3177262A4 (en) 2014-08-08 2018-04-18 Novan Inc. Topical emulsions
WO2017151905A1 (en) 2016-03-02 2017-09-08 Novan, Inc. Compositions for treating inflammation and methods of treating the same
JP6899845B2 (en) 2016-04-13 2021-07-07 ノヴァン，インコーポレイテッド Compositions, systems, kits and methods for treating infectious diseases
US20190351060A1 (en) * 2016-12-16 2019-11-21 Ferring B.V. Rectal Foam Formulations
US11285171B2 (en) 2018-03-01 2022-03-29 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907118A1 (en) 1979-02-20 1980-09-04 Schering Ag NEW PROSTACYCLINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
IT1154655B (en) 1980-05-22 1987-01-21 Alfa Farmaceutici Spa IMIDAZO-RIFAMYCIN DERIVATIVES METHODS FOR THEIR PREPARATION AND USE AS AN ANTIBACTERIAL ACTION SUBSTANCE
IT1199374B (en) 1984-05-15 1988-12-30 Alfa Farmaceutici Spa PROCESS FOR THE PREPARATION OF PIRIDO-IMIDAZO-RIFAMICINE
GB8909559D0 (en) 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
FR2647344B1 (en) 1989-05-25 1995-06-02 Physiopharm Sarl RECTAL USE AEROSOL FOAM
US4946939A (en) 1989-05-30 1990-08-07 The Dow Chemical Company High purity polyether polyols
IT1243379B (en) 1990-07-27 1994-06-10 Giuliani Spa PHARMACEUTICAL COMPOSITION SUITABLE FOR RECTAL ADMINISTRATION OF ACTIVE PRINCIPLES WHICH EXPLICATE A MEDICATION ACTION AT THE LEVEL OF THE COLON, PREVALENTLY TOPICAL
IT1253711B (en) * 1991-12-17 1995-08-23 Alfa Wassermann Spa VAGINAL PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
IT1264494B1 (en) 1993-03-23 1996-09-24 Alfa Wassermann Spa USE OF RIFAXIMIN AND FORMULATIONS THAT CONTAIN IT IN THE TREATMENT OF GASTRIC DYSPEPSIES ORIGINATED BY HELICOBACTER
IT1290679B1 (en) 1997-02-14 1998-12-10 Alfa Wassermann Spa USE OF RIFAXIMINE AND OF THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT IN THE TREATMENT OF DIARRHEA FROM CRYPTOSPORIDIOSIS.
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
ITMI20032144A1 (en) 2003-11-07 2005-05-08 Alfa Wassermann Spa REFLEXIMINE POLIMORPHIC FORMS, PROCESSES TO OBTAIN THEM AND
PL1698630T3 (en) 2005-03-03 2014-12-31 Alfasigma Spa New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
CN101594885B (en) * 2006-03-09 2017-07-18 萨利克斯药品公司 Rifaximin anti-rectal dysfunction preparation
WO2009137672A1 (en) * 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
CN101502510B (en) * 2009-03-19 2011-11-09 山东京卫制药有限公司 Medicament composition for treating colpitis symptoms and preparation method thereof

Also Published As

Publication number Publication date
JP2013511570A (en) 2013-04-04
WO2011061519A3 (en) 2011-10-06
CA2781580A1 (en) 2011-05-26
AU2010320656B2 (en) 2015-07-30
RU2012126084A (en) 2013-12-27
MX2012005883A (en) 2012-10-09
BR112012012316A2 (en) 2016-04-26
AU2010320656A1 (en) 2012-06-21
CN102724960A (en) 2012-10-10
KR20120117788A (en) 2012-10-24
EP2503989A2 (en) 2012-10-03
ZA201204018B (en) 2012-12-27
WO2011061519A2 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
NZ600362A (en) Topical foam composition
PE20080374A1 (en) ROPINIROL PHARMACEUTICAL COMPOSITIONS
WO2008152444A3 (en) Foamable waterless compositions with modulating agents
MY143562A (en) Enhanced oil delivery from structured surfactant formulations
TW200833364A (en) Emulsion composition for hair product
CN106927719B (en) A kind of acrylates combined casting packing material and the preparation method and application thereof
WO2006023496A3 (en) Vaginal cream compositions, kits thereof and methods of using thereof
WO2006032842A3 (en) Foamed cement compositions and associated methods of use
BRPI0509708A (en) pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and / or medium chain triglycerides
NZ600358A (en) Topical foam composition
WO2009149418A3 (en) Compositions for the in vivo delivery of rnai agents
WO2010093523A3 (en) Foamable microemulsion compositions for topical administration
PH12015500127B1 (en) Process for making an improved conditioning composition
MX351347B (en) Endodontic sealing composition.
WO2007031621A3 (en) Metronidazole-based dermatological foam and emulsions for the production thereof
AR065039A1 (en) A PHARMACEUTICAL COMPOSITION OF MODIFIED LIBERATION, A PROCESS FOR ITS PREPARATION, A METHOD FOR ITS USE AND USE
MY162586A (en) The use of glycerol as an agent for improving the self-dispersing property of mineral substances intended for an aqueous composition
WO2008057245A3 (en) Water-based skin care composition with polyalkylsilsesquioxane powder emulsion and method for making the same
NZ609420A (en) Fulvestrant compositions and methods of use
MX2013005621A (en) Biodegradable drug delivery composition.
MX2009013802A (en) Emulsifying polymers and their use.
CN102895134A (en) Slimming warm-up oil
NZ603828A (en) Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
MX2012007227A (en) Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture.
CN102294105A (en) Preparation method of novel anti-solvent aqueous film forming foam extinguishing agent

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 23 NOV 2017 BY BALDWINS INTELLECTUAL PROPERTY

Effective date: 20150326

LAPS Patent lapsed